Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Detection of PPROM With AmniSure PAMG-1 Rapid Immunoassay | Clinical Trials | Clareo Health

Back to search

TERMINATED

Detection of PPROM With AmniSure PAMG-1 Rapid Immunoassay

Detection of Preterm Prelabour Rupture of Membranes With AmniSure Placental Alpha Macroglobulin-1 Rapid Immunoassay

NCT01637610•University of Saskatchewan

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Preterm Premature Rupture of Fetal Membranes

Locations

Canada

Locations (1)

Royal University Hopsital

Saskatoon, Saskatchewan, Canada

Key Dates

Start Date

September 1, 2011

Primary Completion Date

August 1, 2013

Completion Date

January 1, 2014

Last Updated

May 27, 2015

Sponsors

Lead Sponsor

University of Saskatchewan

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 27, 2015Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions